| Meredith Anne Stringer, NP | |
|
1 Medical Center Dr, Lebanon, NH 03756-1000 | |
| (603) 650-5000 | |
| Not Available |
| Full Name | Meredith Anne Stringer |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner - Acute Care |
| Location | 1 Medical Center Dr, Lebanon, New Hampshire |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1003239070 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363LA2100X | Nurse Practitioner - Acute Care | 069521-23 (New Hampshire) | Primary |
| Entity Name | Mary Hitchcock Memorial Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1023092053 PECOS PAC ID: 4486561164 Enrollment ID: O20031126000258 |
News Archive
PerkinElmer Inc., a global leader focused on the health and safety of people and the environment, today announced the launch of the FrontierTM Infrared Spectrometer, a high performance infrared spectrometer built using PerkinElmer's industry-leading spectroscopy expertise.
Mallinckrodt today announced the commercial launch of PENNSAID (diclofenac sodium topical solution) 2% w/w (PENNSAID 2%). PENNSAID 2% is a topical non-steroidal anti-inflammatory drug (NSAID) approved for use in the treatment of the pain of osteoarthritis of the knees.
Approximately 10 percent of newborns require help breathing after birth, and 1 in 1,000 newborns require more intensive resuscitation measures.
New research shows that pre-existing diabetes in pregnant women greatly increases the risk of death of their unborn fetus by around four-and-a-half times compared with pregnant women without diabetes, and also almost doubles the risk of death of infants after birth.
School-based health centers in 29 states will receive $14.5 million to help upgrade their facilities or establish new sites, the Department of Health and Human Services announced Thursday.
› Verified 6 days ago
| Entity Name | Dartmouth-hitchcock Clinic |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1548210198 PECOS PAC ID: 4183537509 Enrollment ID: O20040809000442 |
News Archive
PerkinElmer Inc., a global leader focused on the health and safety of people and the environment, today announced the launch of the FrontierTM Infrared Spectrometer, a high performance infrared spectrometer built using PerkinElmer's industry-leading spectroscopy expertise.
Mallinckrodt today announced the commercial launch of PENNSAID (diclofenac sodium topical solution) 2% w/w (PENNSAID 2%). PENNSAID 2% is a topical non-steroidal anti-inflammatory drug (NSAID) approved for use in the treatment of the pain of osteoarthritis of the knees.
Approximately 10 percent of newborns require help breathing after birth, and 1 in 1,000 newborns require more intensive resuscitation measures.
New research shows that pre-existing diabetes in pregnant women greatly increases the risk of death of their unborn fetus by around four-and-a-half times compared with pregnant women without diabetes, and also almost doubles the risk of death of infants after birth.
School-based health centers in 29 states will receive $14.5 million to help upgrade their facilities or establish new sites, the Department of Health and Human Services announced Thursday.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Meredith Anne Stringer, NP 1 Medical Center Dr, Lebanon, NH 03756-1000 Ph: (603) 650-5000 | Meredith Anne Stringer, NP 1 Medical Center Dr, Lebanon, NH 03756-1000 Ph: (603) 650-5000 |
News Archive
PerkinElmer Inc., a global leader focused on the health and safety of people and the environment, today announced the launch of the FrontierTM Infrared Spectrometer, a high performance infrared spectrometer built using PerkinElmer's industry-leading spectroscopy expertise.
Mallinckrodt today announced the commercial launch of PENNSAID (diclofenac sodium topical solution) 2% w/w (PENNSAID 2%). PENNSAID 2% is a topical non-steroidal anti-inflammatory drug (NSAID) approved for use in the treatment of the pain of osteoarthritis of the knees.
Approximately 10 percent of newborns require help breathing after birth, and 1 in 1,000 newborns require more intensive resuscitation measures.
New research shows that pre-existing diabetes in pregnant women greatly increases the risk of death of their unborn fetus by around four-and-a-half times compared with pregnant women without diabetes, and also almost doubles the risk of death of infants after birth.
School-based health centers in 29 states will receive $14.5 million to help upgrade their facilities or establish new sites, the Department of Health and Human Services announced Thursday.
› Verified 6 days ago
Mrs. Janice M Brennan, APRN Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 1 Medical Center Dr, Dhmc Department Of Occupation Medicine, Lebanon, NH 03756 Phone: 603-560-5000 Fax: 603-650-0787 | |
Carol Williams-suich, ARNP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 5 Alice Peck Day Dr, Lebanon, NH 03766 Phone: 603-448-3122 Fax: 603-448-7491 | |
Cassandra M Godzik, APRN Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: One Medical Center Dr, Lebanon, NH 03756 Phone: 603-650-7232 | |
Deann Opal Mcnamara, APRN Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 1 Medical Center Dr, Lebanon, NH 03756 Phone: 603-650-5922 | |
Emily L Swann, APRN Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 1 Medical Dr, Lebanon, NH 03756 Phone: 603-650-6224 | |
Molly P Keady, APRN Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 1 Medical Center Dr, Lebanon, NH 03756 Phone: 603-650-8622 |